DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fh45nt/competing_in_the) has announced the addition of the "Competing in the US Molecular Diagnostics Market" report to their offering.
This new 880-page report from Venture Planning Group contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including:
- Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
- Five-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases
- Genetic Diseases
- Cancer
- Paternity Testing/HLA Typing
- Forensic Testing
- Review of testing methodologies an instrumentation technologies.
- Feature comparison of automated and semiautomated analyzers.
- Sales and market shares of leading suppliers.
- Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Key Topics Covered:
A. DNA Sequencing
B. DNA And RNA Probe Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and
F. Pharmacogenomics
G. Major Applications
H. Competing/complementing Technologies
I. Worldwide Market Overview
For more information visit http://www.researchandmarkets.com/research/fh45nt/competing_in_the